Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- UK housebuilders face CMA action over leaseholds
4 Sep 2020 - Friday broker round-up
24 Jul 2020 - Countryside Raises GBP250 Million From Share Placing For Covid Relief
23 Jul 2020 - Countryside Properties raises £250m to bolster balance sheet
23 Jul 2020 - Countryside's Quarterly Completions Tumble; Plans Bumper Placing
22 Jul 2020 - Wednesday broker round-up
8 Jul 2020 - Jefferies cuts Crest Nicholson to 'hold' in upbeat sector note
26 Jun 2020 - UK BROKER RATINGS SUMMARY: GS Likes Flutter And JPM Likes William Hill
19 Jun 2020
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
UK housebuilders face CMA action over leaseholds
(Sharecast News) - The UK's competition regulator is taking enforcement action against four of Britain's biggest housebuilders over their treatment of...
Friday broker round-up
(Sharecast News) - Unilever: Barclays upgrades to overweight with a target price of 5,470.0p.
Countryside Raises GBP250 Million From Share Placing For Covid Relief
Countryside Raises GBP250 Million From Share Placing For Covid Relief
Countryside Properties raises £250m to bolster balance sheet
(Sharecast News) - Housebuilder and urban regeneration company Countryside Properties has raised around £250m through a placing and subscription ...
Countryside's Quarterly Completions Tumble; Plans Bumper Placing
Countryside's Quarterly Completions Tumble; Plans Bumper Placing
Wednesday broker round-up
(Sharecast News) - Persimmon: Peel Hunt upgrades to add with a target price of 2,730.0p.
Jefferies cuts Crest Nicholson to 'hold' in upbeat sector note
(Sharecast News) - Jefferies cut its rating on Crest Nicholson shares to 'hold' because of the company's higher-risk profile but the broker was upbeat...
UK BROKER RATINGS SUMMARY: GS Likes Flutter And JPM Likes William Hill
UK BROKER RATINGS SUMMARY: GS Likes Flutter And JPM Likes William Hill
Follow the stocks
